Refine Search
...The study analyzed tissue samples from 189 Jewish patients treated during a 12-year period at Memorial Sloan-Kettering Cancer Center in New York. All of the women had advanced ovarian cancer. Researchers focused on Jewish women because they...
...one of these drugs, code-named IMC-C225. The drug was discovered by Dr. John Mendelsohn at Memorial Sloan-Kettering Cancer Center in New York City and is being developed by ImClone Systems Inc., which is financing the research. Mendelsohn...
...disclosing their products' radiation levels. The new study, co-written by Dr. Mark Malkin of Memorial Sloan-Kettering Cancer Center in New York, involved phone-use questionnaires given to 469 men and women ages 18 to 80 with brain cancer...
...before and after," said Dr. Peter P. Bach, a lung specialist and professor of epidemiology at Memorial Sloan-Kettering Cancer Center in New York. Studies of heart surgery and treatments for a variety of other medical conditions likewise have...
...Cancer Institute. "These studies are fascinating and provocative," said Larry Norton of the Memorial Sloan-Kettering Cancer Center in New York. But Norton said the findings only "hint" at an effect on breast cancer rates from nighttime...
...susceptibility gene that women should be tested for tomorrow," said Dr. Kenneth Offit of the Memorial Sloan-Kettering Cancer Center in New York. On the Net: Science magazine: http://www.sciencemag.org Fanconi Anemia Research Fund...
...two daughters, Ellie, 3; and Kate, 1. Peter recently began undergoing antibody treatments at Memorial Sloan-Kettering Cancer Center in New York City. He spent the Fourth of July there. Peter travels to Manhattan, N.Y., for treatment...
...million each to two hospitals that cared for his wife when she was dying from breast cancer. The Memorial Sloan-Kettering Cancer Center in New York and the Arizona Cancer Center in Tucson, Ariz., will receive the donations. Linda McCartney...
...over doing nothing," said Dr. Joseph J. Disa, a plastic surgeon who performs the surgery at Memorial Sloan-Kettering Cancer Center in New York City. He outlined the new approach Wednesday at an American Cancer Society meeting at Dana Point...
...treatment for specific patients, Gelber said. Dr. Andrew D. Seidman, a breast cancer specialist at Memorial Sloan-Kettering Cancer Center in New York City, said the study "will reaffirm the way that many oncologists are now practicing" and should...